Theravance Biopharma
Nasdaq TBPH · George Town, Grand Cayman, CA
Works in Cardiovascular · Dermatology · GI & liver · Immunology · Infectious disease · Musculoskeletal · Neurology · Psychiatry · Respiratory
Theravance Biopharma is a clinical trial sponsor based in George Town, Grand Cayman, CA, listed as Nasdaq TBPH. It has 1 active clinical trial with 102 planned participants, across 9 therapeutic areas. Since 2021 it has completed 37 trials and stopped 6 early.
Trial track record · since 2021
Financials · Nasdaq TBPH
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Theravance Biopharma
Theravance Biopharma is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 102 planned participants, in Cardiovascular, Dermatology, GI & liver, Immunology and other areas. Since 2021 it has completed 37 trials and stopped 6 early.
Theravance Biopharma is based in George Town, Grand Cayman, CA and is listed as Nasdaq TBPH. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Theravance Biopharma; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-09-05.
Approve Suite is not affiliated with Theravance Biopharma.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.